Medication info
Pritelm Tablets 40 mg (Telmisartan)

Pritelm Tablets 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Chodang Pharmaceutical Co., Ltd.
Appearance
White or off-white oblong tablets
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201209665 · Approved 2012.12.13 · Insurance code 670701690

Summary

Main use
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Chodang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral arterial disease
  • stroke
  • transient ischemic attack
  • and clinical evidence of end-organ damage in high-risk diabetes
  • myocardial infarction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It also helps reduce the risk of mortality due to myocardial infarction, stroke, and cardiovascular diseases in high-risk patients over 55 years of age who cannot use angiotensin-converting enzyme (ACE) inhibitors. This drug protects cardiovascular health in individuals with underlying conditions such as coronary artery disease, peripheral arterial disease, stroke, or diabetes, and is effective in lowering overall cardiovascular disease risk. Therefore, it is used not only for hypertension but also for reducing the risk of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause severe harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Individuals allergic to this drug or its components, pregnant women or women of childbearing potential, nursing mothers, patients with severe liver impairment or biliary obstruction, patients with hereditary angioedema, and those with specific renal dysfunction should not use it. Elderly patients, those with elevated potassium levels, patients with mild liver impairment, patients with heart valve disease or ischemic heart disease, gastrointestinal disease patients, patients with renovascular hypertension, and those with severe renal impairment should use this medication with caution. While taking this drug, various adverse reactions such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, cardiac rhythm disturbances, hypotension, respiratory distress, gastrointestinal disturbances, liver function abnormalities, skin rash, myalgia, or renal dysfunction may be observed, and if any symptoms occur, it is important to consult a physician immediately. If symptoms of hypoglycemia or angioedema occur, discontinue the medication immediately and seek appropriate treatment; quick action is also required if hyperkalemia or renal dysfunction is suspected. Regular monitoring of kidney function and serum electrolyte levels is required during usage, and in cases of decreased blood volume, hypotension may occur, so caution is needed. Additionally, when taking this drug in conjunction with other antihypertensive medications, it may lead to excessively low blood pressure or impact kidney function, so it should be taken as directed by a physician. This medication should not be used during pregnancy and is also advised to be avoided while breastfeeding. Safety and efficacy have not been established for children under 18 years of age, so it is not recommended. Care should be taken when using this medication in elderly patients to avoid excessive blood pressure lowering. In the event of an overdose, hypotension, dizziness, acute renal failure, etc. may occur, requiring immediate medical treatment, and this medication cannot be removed through dialysis, so caution is necessary. This medication should be kept out of reach of children and should be consumed immediately after opening the package.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 102 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • indigestion
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic epidermal necrolysis
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • elevated serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • fever
  • pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • flushing
  • erectile dysfunction
  • diminished appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold environments.

Appearance and packaging

Appearance

White or off-white oblong tablets

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.